Device maker Synovis Life Technologies Inc. said its board of directors authorized the company to repurchase up to 1 million shares of its common stock.
Synovis’ board gave it plenty of leeway for the buyback. There’s no expiration date and no minimum purchase amount, according to a statement from the company.
The company seeks to buy back shares because it believes its stock is undervalued, according to CEO Richard Kramp.